
An advisory panel to the Food and Drug Administration will meet Monday to discuss Avandia a diabetes medication. They will also discuss the safety of Actos a diabetes drug, reported the USA Today.
They will hear from Steven Nissen of Cleveland Clinic whose study touched off a firestorm about the safety of the two drugs. The panel could recommend no change up to withdrawal of the drugs from the market. Glaxo-Kline continues to hold steadfast their drugs are safe.